Collegium Pharmaceutical Inc COLL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $35.23
- Day Range
- $34.65–35.54
- 52-Week Range
- $29.19–50.79
- Bid/Ask
- $34.70 / $34.82
- Shares Outstanding
- 32.43M
- Market Cap
- $1.13B
- Volume/Avg
- 343,220 / 454,810
Key Statistics
- Price/Earnings (Normalized)
- 5.46
- Price/Sales
- 1.81
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- 2.22%
Company Profile
Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 423
- Website
- https://www.collegiumpharma.com
Valuation
|
Metric
|
COLL
|
|---|---|
Price/Earnings (Normalized) | 5.46 |
Price/Book Value | 3.61 |
Price/Sales | 1.81 |
Price/Cash Flow | 4.31 |
Price/Earnings
COLL
Financial Strength
|
Metric
|
COLL
|
|---|---|
Quick Ratio | 1.50 |
Current Ratio | 1.71 |
Interest Coverage | 2.23 |
Quick Ratio
COLL
Profitability
|
Metric
|
COLL
|
|---|---|
Return on Assets (Normalized) | 18.49% |
Return on Equity (Normalized) | 111.05% |
Return on Invested Capital (Normalized) | 31.63% |
Return on Assets
COLL
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|Dm?<z@< | LOCK|x>yn& | $69B | |||
| Haleon PLC ADR
HLN
| LOCK|Qf&W!d | LOCK|FM | $43B | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| LOCK|VDXLRZ<v | LOCK|T&$&q | $38B | |||
| Zoetis Inc Class A
ZTS
| LOCK|QX@@%FK | LOCK|>D | $32B | |||
| Viatris Inc
VTRS
| LOCK|pSHY#< | LOCK|?m | $19B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|KB> | LOCK|w@% | $13B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|@G!<PQ | LOCK|n#p | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|>dg!%VY | LOCK|p@M | $8B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|h>$r^@ | LOCK|>$^G$ | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|yM&^G? | LOCK|&X | $1B |
United States